Table 1.

List of cell lines used in this study.

Name	Morphology	Media/Supplements	Disease/Normal	Age of patients	Ref.
Hs 578Bst	fibroblast (myoepithelial)	DMEM/10% FBS/30ng/mL EGF	normal breast tissue peripheral to the source for Hs 578T	74	26
Hs 578T	epithelial	DMEM/10% FBS/10μg/mL insulin/2mM L-glutamine	infiltrating ductal carcinoma	74	26
MCF-7	epithelial	MEM/10% FBS/10μg/mL insulin/2mM L-glutamine	adenocarcinoma in pleural effusion	69	27
MDA-MB-134	epithelial	Leibovitz-15/10% FBS/2mM L-glutamine/10mM HEPES	ductal carcinoma in pleural effusion	47	28
MDA-MB-231	epithelial	DMEM/10% FBS/2mM L-glutamine	adenocarcinoma in pleural effusion	51	29, 30
MDA-MB-435	long thin epithelial-like	DMEM/10% FBS/0.5% non-essential amino acids	adenocarcinoma in pleural effusion	31	31, 32
SK-BR-3	epithelial-like	RPMI 1640/20% FBS/2mM L-glutamine	adenocarcinoma in pleural effusion	43	33 34
T-47D	epithelial	RPMI 1640/10% FBS/2mM L-glutamine/μg/mL insulin/30ng/mL EGF	ductal carcinoma in pleural effusion	54	35
ZR-75-1	epithelial	RPMI 1640/10% FBS	infiltrating ductal adenocaricinoma in ascites	63	36